Cargando…
Immediate Response to Brentuximab Vedotin in a Patient with Localized MF-LCT
The large cell transformation of mycosis fungoides (MF-LCT) is a phenomenon observed in the advanced stages of mycosis fungoides (MF), which is the most common primary cutaneous lymphoma. The diagnostic criteria of MF-LCT are a minimum of 25% of large cells or a formation of microscopic nodules of t...
Autores principales: | Giza, Agnieszka, Miklusiak, Karol, Hałubiec, Przemysław, Jaworek, Andrzej, Zimowska-Curyło, Dagmara, Dyduch, Grzegorz, Sacha, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368084/ https://www.ncbi.nlm.nih.gov/pubmed/37497303 http://dx.doi.org/10.1159/000529576 |
Ejemplares similares
-
Brentuximab Vedotin
Publicado: (2012) -
Brentuximab vedotin induced uveitis
por: Therssen, Stijn, et al.
Publicado: (2022) -
Brentuximab Vedotin in CD30+ Lymphomas
por: Perini, Guilherme Fleury, et al.
Publicado: (2013) -
Brentuximab vedotin: axonal microtubule's Apollyon
por: Mariotto, S, et al.
Publicado: (2015) -
Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma
por: Chen, Runzhe, et al.
Publicado: (2015)